Antimicrobial Activity of the Methanolic and Crude Alkaloid Extracts of Acalypha wilkesiana cv. macafeeana Copper Leaf
The antimicrobial activity of methanolic leaf extracts and crude alkaloid extracts of A. wilkesiana cv. macafeeana was evaluated after a preliminary phytochemical screening of the leaf extracts. The standard agar well diffusion method was used in the bioassay involving test bacteria and yeast isolates, while percentage inhibition of extracts on radial growths of the molds was determined. The Minimal Inhibitory Concentrations (MIC) and Minimal Bactericidal Concentrations (MBC) were also determined by the broth microdilution assay technique. The microorganisms used were clinical strains of Escherichia coli, Salmonella typhi, Streptococcus pyogenes, Strept. pneumonia, Methicillin-Resistant Staphylococcus aureus (MRSA), non-methicillin resistant Staph. aureus, Candida albicans, Aspergillus fumigatus and A. flavus. Alkaloids, tannins, terpenoids and cardiac glycosides were extracted by the methanol solvent. The crude alkaloid extracts inhibited only the Gram-negative bacteria with mean inhibition zones of 10.0±0.00 to 12.3±0.03 mm while the methanol extracts inhibited all other test organisms, a broad spectrum activity. The water extracts had no activity against the non-MRSA strains. The MIC was 0.4 mg mL-1 for all unicells except strains of C. albicans which both had MICs of 0.8 mg mL-1. The MBC was 0.4 mg mL-1 for tested isolates except the non-MRSA and C. albicans which had MBCs of >12.0 mg mL-1 and 1.0 mg mL-1, respectively. The methanolic extract totally inhibited all tested aspergilli while the water extract had a varying inhibitory effect (63.0±2.50 to 81.0±2.90%) on the tested fungi strains. The alkaloid had no effect on the molds.
The use of plant, plant extract or plant-derived chemicals to treat diseases;
topical, subcutaneous and systemic, has stood the test of time (Oladunmoye,
2006). In recent years, there has been a gradual revival of interest in the
use of medicinal plants in developing countries because herbal medicines have
been reported safe and without any adverse side effect especially when compared
with synthetic drugs (Iniaghe et al., 2009). Also, there has been little
or no report of any form of microbial resistance during the use and administration
of herbal medicines (Stephen et al., 2009). More importantly in Africa,
particularly West Africa, new drugs are often beyond the reach of the poor such
that up to 80% of the population use medicinal plants as remedy against infections
and diseases (Kirby, 1996; Hostettmann and Maston, 2002).
Acalypha wilkesiana belongs to the family euphorbiaceae and grows as an annual bedding plant (Oladunmoye, 2006). This large, fast-growing, evergreen shrub provides a continuous splash of colour in the landscape with the bronze red to muted red, 4 to 8 inch long, heart-shaped leaves available in varying mottled combinations of green, purple, yellow, orange, pink, or white, depending upon cultivar (Gilman, 1999). Although, there are quite a reasonable number of cultivars worldwide, the macrophylla, hoffamanii, godseffiana, macafeeana, hispida, marginata and racemosa are peculiar cultivars within Nigeria (Oladunmoye, 2006; Yushau et al., 2008; Iniaghe et al., 2009).
Investigations have been carried out on almost all the available cultivars within Nigeria with respect to their phytochemicals and antimicrobial action against medically inclined and agriculturally related pathogens (Akinde and Odeyemi, 1987; Alade and Irobi, 1993; Adesina et al., 2000; Oladunmoye, 2006; Ogbo and Oyibo, 2008). Consequently, this plant has been reported to specifically have antibacterial and antifungal properties (Alade and Irobi, 1993) as the expressed juice or boiled decoction is locally used within Nigeria and some other parts of West Africa for the treatment of malaria, dermatological and gastrointestinal infections (Akinde and Odeyemi, 1987). There was however no available report to us on the phytochemical screening of the macafeeana cultivar using methanol as the extraction solvent, extraction of alkaloid from this cultivar and antimicrobial activity of its methanol extract and alkaloid, therefore the need for this study.
MATERIALS AND METHODS
Plant Material, Phytochemical Extraction and Screening
Fresh leaves of A. wilkesiana cv. macafeeana were obtained
from the Horticulture Garden in Babcock University, Nigeria where this study
was carried out between May, 2008 and April, 2009. The identity of the plant
was authenticated by a Plant Taxonomist within the Plant Sciences unit of the
Department of Chemical and Environmental Sciences, Babcock University.
The leaf samples were air dried for 3 weeks, pulverized into uniform powder using a blender and extracted using methanol. Fifty grams of the pulverized leaves was soaked in 500 mL absolute methanol (Sigma, USA) for 24 h in a 1 L conical flask after which filtration of the mixture followed using two folds of Whatman No. 1 filter paper. The extract was then concentrated at 40°C in a vacuum using rotary evaporator (Eyela Rotavap N-1001, Rikakikai Co. Ltd., Tokyo). The same procedure was used in the distilled water extraction of phytochemicals.
The phytochemicals screened for were alkaloids, tannins, phlobatannins, saponins, flavonoids, steroids and cardiac glycosides using standard procedures as described by Harborne (1973) and Sofowora (1993).
Crude Alkaloid Extraction
Crude alkaloid was extracted following the method reported by Adeniyi et
al. (2009). Briefly, 20 g of the ground leaf was weighed and dispensed into
200 mL of 10% (v/v) acetic acid solution in ethanol. The mixture was well shaken
and allowed to stand for 4 h before filtering using two folds of Whatman No.
1 filter paper. The filtrate was then evaporated to one quarter of its original
volume on a heating mantle. Concentrated ammonium hydroxide was added drop wise
in order to precipitate the alkaloids. A pre-weighed Whatman No. 1 filter paper
was used to filter off the precipitate and it was then washed with 1% ammonium
hydroxide solution. The filter paper containing the precipitate was oven-dried
to constant weight at 60°C for 30 min and cooled in a desiccator. About
0.4 g of the dried precipitate was dissolved in 5 mL distilled water and tested
for the presence of alkaloid using few drops of the Dragendoffs reagent
(solution of potassium bismuth iodide). An orange colored precipitate confirmed
the presence of alkaloid. The percentage weight of the alkaloid was determined
using the formula:
where, W2 is weight of crude alkaloid on filter paper, W1 is weight of filter paper and W0 is weight of powdered sample used for extraction (20 g).
Source of Microorganism
Microorganisms used were fresh clinical isolates from Babcock University
Medical Centre and Olabisi Onabanjo University Teaching Hospital, Nigeria. Isolate
selection was dependent upon their availability and confirmed taxonomy, thus
the isolates represented pathogens of both topical and systemic diseases. The
bacteria were identified as: Streptococcus pyogenes (4 isolates), Strept.
pneumonia (2 isolates), Methicillin-Resistant Staphylococcus aureus
(MRSA) (2 isolates), Staph. aureus (2 isolates), Escherichia
coli (2 isolates) and Salmonella typhi (2 isolates), using the conventional
biochemical and physiological tests described by MacFaddin (2000), Fobres et
al. (2002) and Leboffe and Pierce (2002). The Bergeys Manual of Systematic
Bacteriology (Sneath et al., 1986) was used for species authentication.
The Staph. aureus isolates were confirmed as either MRSA or non-MRSA
by serological methods using the Staphytect Plus Reagent kit (DR0850, Oxoid,
UK). The fungi used were: Candida albicans (2 isolates), Aspergillus
fumigatus (2 isolates) and A. flavus (1 isolates), as identified
via macroscopic and microscopic observations as well as germ tube test and chlamydospore
production on cornmeal agar fortified with Tween 80 polysorbate for the yeast
(Bulmer, 1978; Domsch et al., 1980; Brown, 2005).
The standard agar well diffusion method as described by Perez et al.
(1990) was used in the bioassay involving the bacteria and yeast isolates while
the Minimal Inhibitory Concentrations (MIC) and Minimal Bactericidal Concentrations
(MBC) were determined following the broth microdilution assay technique recommended
by the National Committee for Clinical Laboratory Standards (NCCLS, 2000). Dimethyl
sulfoxide (DMSO) was used as dissolving solvent while the dilutions ranged from
0.1 to 12.0 mg mL-1. Two commercial antibiotics, Ciprofloxacin and
Penicillin, served as positive controls for the well diffusion assay. The methanolic
extract was used for the MIC and MBC. Agar wells were punched using 5 mm cork
The effect of the extracts on the radial growth of the filamentous fungal isolates
was determined by slightly modifying the method described by Amadioha (2002).
Briefly, 1 mL of each extract (12 mg mL-1) was spread separately
on the surface of sterile solidified Potato Dextrose Agar (PDA) to give the
extract-PDA medium. One milliliter each of sterile distilled water and methanol
served separately as the controls. Five millimeter disc of each isolate was
cut from a 3 days active culture on PDA and placed separately at the center
of the Petri dish containing the corresponding extract-PDA medium. All control
plates containing the inocula and methanol were wrapped carefully in aluminum
foil to prevent volatilization of the solvent. The plates were allowed to stand
for 5 h before incubation at 30°C for 5 days. At the end of incubation,
radial growths of isolates were measured and the percentage inhibition of various
concentrations determined as described by Ogbo and Oyibo (2008). All assays
were carried out in triplicates to calculate the mean results.
The inherent bioactive phytochemicals in the A. wilkesiana cv. macafeeana leaves are shown in Table 1. Methanol as extraction solvent showed a better capacity for extracting total phytochemicals than distilled water and this is evident in the number of phytochemicals extracted and the overall yield of the extracts. Alkaloids and Tannins were present in extracts of both solvents while Terpenoids and Cardiac glycosides were only extracted by methanol. The total extracts yield by methanol was 7.72 g while the water extracts yield was 6.81 g. The percentage crude alkaloid extract was 3.70%.
The in vitro inhibitory activity of the extracts revealed that the crude
alkaloid extracts were active only against the Gram-negative bacteria (strains
of E. coli and S. typhi) with mean inhibition zones ranging from
10.0±0.00 to 12.3±0.03 mm, while the methanol and water extracts
of total phytochemicals were active against all other test organisms, a broad
spectrum of activity. The water extracts had no activity against the non-MRSA
strains (Table 2). The streptococci were the most susceptible
unicells to the methanol and water extracts of the total phytochemicals with
mean inhibition zones of 19.7±0.04 to 24.0±0.00 mm and 15.7±0.04
to 21.3±0.03 mm, respectively. Figure 1 shows the zones
of inhibition of some of the concentrations of the crude alkaloid extract against
E. coli (OS12) while Fig. 2 and 3
show the zones of inhibition of the methanol extract against Staph. aureus
(BM18) and C. albicans (OS12).
||Phytochemical analysis of the methanol and water extracts
of A. wilkesiana cv. macafeeana
||Zones of inhibition (mm) of leaf extracts of A. wilkesiana
cv. macafeeana and standard antibiotics on unicellular microorganisms
|Results are means of triplicate treatments with standard deviations.
nz: No zone of inhibition, ME: Methanolic extract, WE: Water extract, AK:
Crude alkaloid extract, PEN: Penicillin; CP: Ciprofloxacin, MRSA: Methicillin
resistant Staph. aureus
||Zones of inhibition of some concentrations of the crude alkaloid
extract against E. coli (OS12). 1: 9.6 mg mL-1,
2: 3.2 mg mL-1, 3: 3.2 mg mL-1, 4: 1.6 mg mL-1,
5: 0.8 mg mL-1
||Zones of clearance of the methanol extract against Staph.
aureus (BM18). 1: 9.6 mg mL-1, 2: 3.2 mg mL-1,
3: 3.2 mg mL-1, 4: 1.6 mg mL-1, 5: 0.8 mg mL-1
The MIC, expressed as the lowest extract concentration at which no visible growth in broth was observed, was 0.4 mg mL-1 for all unicellular isolates except strains of C. albicans which both had MICs of 0.8 mg mL-1 (Table 3). The MBC, recorded as the lowest extract concentration that exhibited capacity to kill 99.9% of unicell inocula, was 0.4 mg mL-1 for tested isolates except the non-MRSA and C. albicans which had MBCs of >12.0 and 1.0 mg mL-1, respectively.
The results of the effect of the extracts on the radial growth of the filamentous
fungal isolates are shown in Table 4. The methanolic extract
totally inhibited all tested aspergilli (100% inhibition), while the water extract
had a varying inhibitory effect on the strains tested. The alkaloid had no effect
on the molds.
||Zones of inhibition of some concentrations of the methanol
extract against C. albicans (OS12). 1= 9
||The MIC and MBC of leaf extracts of A. wilkesiana cv.
macafeeana on unicellular microorganisms
|MIC: Minimum inhibitory concentration, MBC: Minimum bactericidal
||Inhibition (%) of strains of Aspergillus by leaf extracts
of A. wilkesiana cv. macafeeana
|Results are means of triplicate treatments with standard error.
nz: No zone of inhibition, ME: Methanolic extract, WE: Water extract AK:
Crude alkaloid extract
The difference in the yield weights of the methanol and water extracts may be attributed to the number and quantity of absent bioactive molecules when water was used as extracting solvent. The presence of alkaloids, tannins, terpenoids and cardiac glycosides in the methanol extracts show its capacity to serve as an extraction solvent for phytochemicals from A. wilkesiana cv. macafeeana leaves.
The results of the in vitro inhibitory activity of the crude alkaloids, the methanol and water extracts are quite appreciable when compared to the mean inhibition zones produced by the control antibiotics and the fact that the standard antibiotics are in the purified and concentrated form whereas the extracts are crude and harbor both pharmacologically and non-pharmacologically active compounds. The susceptibility of the tested MRSA strains show that the total leaf extracts could be used as an alternative in treating staphylococcal infections resulting from MRSA pending when the active ingredients of this plant would be isolated, chemically identified and purified for commercial use. This is in line with the findings of Stephen et al. (2009), who reported that MRSA are highly susceptible to crude extracts of Khaya grandifoliola stem bark as compared to commercial antibiotics.
Alkaloids generally have been noted for their antimalarial and antibacterial activities although it seems their mechanism of action on microbes remains unclear (Karou et al., 2005; Raghavendra et al., 2008). The susceptibility of only the Gram-negative bacteria to the alkaloid extract is interesting as we may suggest that there could have been a possible interaction between these alkaloids and some constituents of the Gram-negative cell wall thereby causing cytotoxic damage to this group of bacteria. This suggestion is on the basis that structurally, Gram-positive and Gram-negative bacteria differ only in their cell wall composition. Therefore the alkaloid extract could be explored as a narrow spectrum herbal drug especially in cases of gastrointestinal infections since the tested bacteria strains are clinical isolates.
The MIC values are remarkable for a crude extract as well as the MBC values except for the MBC for non-MRSA. The result obtained shows that these staphylococci may be inhibited by a very low concentration of the extract while all studied concentrations had no capacity to trigger lysis of the cells by activation of autolytic enzymes in the cell wall. This situation may be referred to as tolerance, a resistance mechanism, due to the large difference between the MIC and MBC (Brooks et al., 1998). This therefore shows that this plant extract may not be suitable as a bactericidal agent in the case of infections arising from non-MRSA unless combined herbal therapies are explored.
The inhibitory mechanism of the total phytochemicals extracted with methanol on the radial growth of the filamentous fungi could be that of blocking the synthesis of the cell wall constituents or a possible interference with the replication of genetic material so as to prevent cell division since it was recorded that the molds did not grow at all.
From present study we can conclude that crude alkaloids can be extracted as well as total phytochemicals from A. wilkesiana cv. macafeeana and that the alkaloids can significantly inhibit the growth of Gram-negative bacteria only, an indication that if commercially produced could serve as a good first line drug for infections, mainly gastrointestinal, caused by Gram-negative bacteria. Also, that the methanolic leaf extract of this plant of pharmacological importance has a broad spectrum of activity against bacteria (Gram-positive and negative) and fungi (yeasts and molds) of clinical origin. Further studies on this plant are encouraged so as to extract, identify and formulate the active molecules into appropriate dosage forms. This is the first available report on the application of methanol as extraction solvent for phytochemicals from A. wilkesiana cv. macafeeana leaves, the extraction of crude alkaloids from this cultivar and antimicrobial testing of its methanol extract and alkaloids.
1: Adeniyi, S.A., C.L. Orjiekwe and J.E. Ehiagbonare, 2009. Determination of alkaloids and oxalates in some selected food samples in Nigeria. Afr. J. Biotechnol., 8: 110-112.
Direct Link |
2: Adesina, S.K., A.O. Ogundaini, H. Oladimeji and T.A. Olugbade, 2000. Antimicrobial Constituents of the Leaves of Acalypha wilkesiana. John Wile and Sons, New York, Pages: 120.
3: Akinde, B.E. and O.O. Odeyemi, 1987. Extraction and microbiological evaluation of the oils from the leaves of Acalypha wilkesiana. Nig. Med. J., 17: 163-165.
4: Alade, P.I. and O.N. Irobi, 1993. Antimicrobial activities of crude extracts of Acalypha wilkesiana. J. Ethnopharmacol., 39: 171-171.
5: Amadioha, A.C., 2002. Fungitoxic effects of extracts of Azadirachta indica against Cochliobolus miyabeanus causing brown spot disease of rice. Arch. Phytopathol. Plant Prot., 35: 37-42.
Direct Link |
6: Brooks, G.F., J.S. Butel and S.A. Morse, 1998. Jawetz, Melnick and Adelberg's Medical Microbiology. 21st Edn., McGraw-Hill, New York.
7: Brown, A.E., 2005. Benson's Microbiological Application. 9th Edn., McGraw-Hill, New York.
8: Bulmer, G.S., 1978. Medical Mycology. 1st Edn., Scope Publication, UK.
9: Domsch, K.H., W. Gams and T.H. Anderson, 1980. Compendium of Soil Fungi. Academic Press, New York.
10: Fobres, B., D. Sham and A. Weissfield, 2002. Diagnostic Microbiology. 11th Edn., Andrew Allen Press, Canada.
11: Gilman, E.F., 1999. Acalypha wilkesiana, Fact sheet FPS-6. University of Florida Extension Service. pp: 1-3.
12: Harborne, J.B., 1973. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. 1st Edn., Chapman and Hall, London, UK., ISBN: 978-94-009-5921-7, Pages: 271.
13: Hostettmann, K. and A. Marston, 2002. Twenty years of research into medicinal plants: Results and perspectives. Phytochem. Rev., 1: 275-285.
CrossRef | Direct Link |
14: Iniaghe, O.M., S.O. Malomo and J.O. Adebayo, 2009. Proximate composition and phytochemical constituents of leaves of some Acalypha species. Pak. J. Nutr., 8: 256-258.
CrossRef | Direct Link |
15: Karou, D., A. Savadogo, A. Canini, S. Yameogo and C. Montesano et al., 2005. Antibacterial activity of alkaloids from Sida acuta. Afr. J. Biotechnol., 4: 1452-1457.
Direct Link |
16: Kirby, G.C., 1996. Medicinal plants and the control of protozoal disease, with particular reference to malaria. Trans. R. Soc. Trop. Med. Hyg., 90: 605-609.
PubMed | Direct Link |
17: Leboffe, M.J. and B.E. Pierce, 2002. Microbiology Laboratory Theory and Application. 1st Edn., Morton Publishing, USA.
18: MacFaddin, J.F., 2000. Biochemical Tests for Identification of Medical Bacteria. 3rd Edn., Williams and Wilkins, Lippincott, New York, ISBN: 0-683-05318-3.
19: NCCLS, 2000. Methods of Dilution, Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 5th Edn., Vol. 17, National Committee for Clinical Laboratory Standards, Wayne, PA, USA.
20: Ogbo, E.M. and A.E. Oyibo, 2008. Effects of three plant extracts (Ocimum gratissimum, Acalypha wilkesiana and Acalypha macrostachya) on post harvest pathogen of Persea americana. J. Med. Plants Res., 2: 311-314.
21: Oladunmoye, M.K., 2006. Comparative evaluation of antimicrobial activities and phytochemical screening of two varieties of Acalypha wilkesiana. Trends Applied Sci. Res., 1: 538-541.
CrossRef | Direct Link |
22: Perez, C., M. Pauli and P. Bazerque, 1990. An antibiotic assay by the agar-well diffusion method. Acta Biol. Med. Exp., 15: 113-115.
Direct Link |
23: Raghavendra, M.P., S. Satish and K.A. Raveesha, 2008. In vitro antibacterial potential of alkaloids of Samanea saman (Jacq.) Merr. against Xanthomonas and human pathogenic bacteria. World J. Agric. Sci., 4: 100-105.
24: Sneath, P.H.A., N.S. Mair, M.E. Sharpe and J.G. Holt, 1986. Bergeys Manual of Systematic Bacteriology. Vol. 2, Williams and Wilkins, Philadelphia.
25: Sofowora, A., 1993. Medicinal Plants and Traditional Medicines in Africa. Spectrum Books Ltd., Ibadan, Pages: 289.
26: Stephen, U.A., F. Abiodun, O. Osahon and E. Ewaen, 2009. Phytochemical analysis and antibacterial activity of Khaya grandifoliola stem bark. J. Biol. Sci., 9: 63-67.
CrossRef | Direct Link |
27: Yusha'u, M., B.S. Aliyu and S.O. Olonitola, 2008. Preliminary screening of acalypha extracts for in vitro inhibitory activity against extended-spectrum β-lactamase producing enterobacteriaceae. Int. J. P. Applied Scs., 2: 1-5.
Direct Link |